RIDGELINE THERAPEUTICS INC
US UEI KM9RHDLMHTN5 · SME
9public awards
$13.5Mtotal public funding
2026-07-28latest award
State aid awards (9)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-28 | $2.2M | Grant | AGING RESEARCH | Department of Health and Human Services |
| 2026-03-02 | $4.2M | Grant | AGING RESEARCH | Department of Health and Human Services |
| 2026-01-29 | $322k | Grant | AGING RESEARCH | Department of Health and Human Services |
| 2025-09-22 | $1.3M | Grant | Preclinical validation of a novel adjunct small molecule drug to preve | Department of Health and Human Services |
| 2023-09-01 | $322k | Grant | A Novel Small Molecule Oral Therapeutic to Prevent and Reverse Skeleta | Department of Health and Human Services |
| 2021-09-30 | $4.2M | Grant | Preclinical Development of a Novel Therapeutic to Rejuvenate Aging Mus | Department of Health and Human Services |
| 2019-09-16 | $252k | Grant | Preclinical studies to validate the efficacy of novel mechanism-of-act | Department of Health and Human Services |
| 2018-09-30 | $358k | Grant | Dose-ranging safety and efficacy studies to advance novel mechanism-of | Department of Health and Human Services |
| 2018-09-01 | $300k | Grant | Dose-ranging safety and efficacy studies to advance novel mechanism-of | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →